WebHHS Headquarters Mailing Address and Telephone Number. The U.S. Department of Health & Human Services Hubert H. Humphrey Building. 200 Independence Avenue, S.W. Washington, D.C. 20241 Toll Free Call Center: 1-877-696-6775. Visiting the SW Complex WebAustin headquarters North Austin Complex 4601 W. Guadalupe St. Austin, TX 78751-3146. Mailing address P.O. Box 85200 Austin, TX 78708. OIG fraud hotline: 800-436-6184 Main number: 512-491-2000 Sign up for email updates
Unaccompanied Children Information HHS.gov
WebThe OIG operates a hotline where DHS employees and others can report fraud, waste, abuse and mismanagement, or other criminal or noncriminal misconduct. The toll-free numbers to call are 1 (800) 323-8603, and TTY 1 (844) 889-4357. We prefer you use our Hotline Allegation Form, which allows you to report allegations in detail and to include ... WebThe OIG is prohibited from providing you with an update on the status of any open investigation. To report fraud, waste, or abuse in a Texas health and human services program, call the OIG Fraud Hotline at 800-436-6184 or use the online reporting tool here. To report fraud, waste, or abuse regarding the expenditure of other state funds, contact ... signs of neck and throat cancer
U.S. Department of Health and Human Services USAGov
WebHHS-OIG is the largest inspector general's office in the Federal Government, with more than 1,600 employees dedicated to government oversight, combating fraud, waste and … OIG Freedom of Information Officer Cohen Building, Suite 1062 U.S. Department of … Criminal, civil or administrative legal actions relating to fraud and other alleged … OIG provides oversight of the Unaccompanied Alien Children program … WebCOVID-19 Update. Consistent with CDC guidance, most Office of Inspector General employees are currently serving the American people remotely. We are determined to keep interruptions to our operations to a minimum, and we appreciate your patience during this time. Information and guidance about COVID-19 is available at coronavirus.gov. therapie bei diabetes typ 1